Nanochon Chondrograft First in Human (FIH) Early Feasibility Study (EFS) - Canada — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Nanochon Chondrograft First in Human (FIH) Early Feasibility Study (EFS) - Canada — Stella

Recruiting

Back to Knee Cartilage Lesions trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(3 sites)

Canada

Fraser Orthopaedic Institute, New Westminster, British Columbia

University of British Columbia, Vancouver, British Columbia

Michael Garron Hospital, Toronto, Ontario

Key details

Sponsor

Nanochon, Inc.

Enrollment target

~10 participants

Started

April 2026

Primary completion

August 2027

Age range

22 Years – 60 Years

Last updated April 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov